Triple
T21289787
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Paul Schimmel |
E524754
|
entity |
| Predicate | coFounded |
P104
|
FINISHED |
| Object | Cubist Pharmaceuticals |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cubist Pharmaceuticals | Statement: [Paul Schimmel, coFounded, Cubist Pharmaceuticals]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Cubist Pharmaceuticals Context triple: [Paul Schimmel, coFounded, Cubist Pharmaceuticals]
-
A.
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
-
B.
Millennium Pharmaceuticals
Millennium Pharmaceuticals is a biotechnology company known for developing innovative cancer therapies, including the proteasome inhibitor bortezomib (Velcade) for multiple myeloma.
-
C.
Mapp Biopharmaceutical
Mapp Biopharmaceutical is a U.S.-based biotechnology company best known for developing antibody-based therapies for infectious diseases, including experimental treatments for Ebola.
-
D.
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a biopharmaceutical company specializing in developing and commercializing innovative medicines for sleep disorders, oncology, and rare diseases.
-
E.
Cubic Corporation
Cubic Corporation is a technology-driven defense and transportation solutions company known for providing fare collection systems, training, and mission support services to governments and transit agencies worldwide.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Cubist Pharmaceuticals Target entity description: Cubist Pharmaceuticals was a biopharmaceutical company best known for developing and commercializing antibiotics to treat serious and drug-resistant infections.
-
A.
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
-
B.
Millennium Pharmaceuticals
Millennium Pharmaceuticals is a biotechnology company known for developing innovative cancer therapies, including the proteasome inhibitor bortezomib (Velcade) for multiple myeloma.
-
C.
Mapp Biopharmaceutical
Mapp Biopharmaceutical is a U.S.-based biotechnology company best known for developing antibody-based therapies for infectious diseases, including experimental treatments for Ebola.
-
D.
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a biopharmaceutical company specializing in developing and commercializing innovative medicines for sleep disorders, oncology, and rare diseases.
-
E.
Cubic Corporation
Cubic Corporation is a technology-driven defense and transportation solutions company known for providing fare collection systems, training, and mission support services to governments and transit agencies worldwide.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b5171f6c8190a5d57201ede73811 |
completed | April 16, 2026, 10:08 a.m. |
| NER | Named-entity recognition | batch_69e736d9467881908ec5b1dec76e6f5d |
completed | April 21, 2026, 8:35 a.m. |
Created at: April 16, 2026, 4:03 p.m.